Literature DB >> 9669273

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.

M A Mathier1, G A Rose, M A Fifer, M I Miyamoto, R E Dinsmore, H H Castaño, G W Dec, I F Palacios, M J Semigran.   

Abstract

OBJECTIVES: This study sought to determine whether coronary endothelial dysfunction exists in patients with acute-onset idiopathic dilated cardiomyopathy (DCM) and to explore its relation to recovery of left ventricular systolic function in this patient population.
BACKGROUND: Coronary endothelial dysfunction exists in chronic DCM, but its importance in the development and progression of ventricular dysfunction is not known. To address this issue we studied coronary endothelial function in patients with idiopathic DCM <6 months in duration and explored the relation between coronary endothelial function and subsequent changes in left ventricular ejection fraction (LVEF).
METHODS: Ten patients with acute-onset idiopathic DCM (duration of heart failure symptoms 2.0 +/- 0.4 months [mean +/- SEM]) and 11 control patients with normal left ventricular function underwent assessment of coronary endothelial function during intracoronary administration of the endothelium-dependent vasodilator acetylcholine and the endothelium-independent vasodilator adenosine. Coronary cross-sectional area (CSA) was determined by quantitative coronary angiography and coronary blood flow (CBF) by the product of coronary CSA and CBF velocity measured by an intracoronary Doppler catheter. Patients with DCM underwent assessment of left ventricular function before and several months after the study.
RESULTS: Acetylcholine infusion produced no change in coronary CSA in control patients but significant epicardial constriction in patients with DCM (-36 +/- 11%, p < 0.01). These changes were associated with increases in CBF in control patients (+118 +/- 49%, p < 0.01) but no change in patients with DCM. Infusion of adenosine produced increases in coronary caliber and blood flow in both groups. Follow-up assessment of left ventricular function was obtained in nine patients with DCM 7.0 +/- 1.7 months after initial study, at which time LVEF had improved by > or =0.10 in four patients. Multiple linear regression revealed a positive correlation between both the coronary CSA (r2 = 0.57, p < 0.05) and CBF (r2 = 0.68, p < 0.01) response to acetylcholine and the subsequent improvement in LVEF.
CONCLUSIONS: Coronary endothelial dysfunction exists at both the microvascular and the epicardial level in patients with acute-onset idiopathic DCM. The preservation of coronary endothelial function in this population is associated with subsequent improvement in left ventricular function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669273     DOI: 10.1016/s0735-1097(98)00209-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

Review 1.  The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.

Authors:  Kyra E Pyke; Michael E Tschakovsky
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

2.  Elastic properties of peripheral arteries in heart failure patients in comparison with normal subjects.

Authors:  Chengyu Liu; Dingchang Zheng; Lina Zhao; Peng Li; Bin Li; Alan Murray; Changchun Liu
Journal:  J Physiol Sci       Date:  2013-03-22       Impact factor: 2.781

Review 3.  Soluble guanylate cyclase: a potential therapeutic target for heart failure.

Authors:  Mihai Gheorghiade; Catherine N Marti; Hani N Sabbah; Lothar Roessig; Stephen J Greene; Michael Böhm; John C Burnett; Umberto Campia; John G F Cleland; Sean P Collins; Gregg C Fonarow; Phillip D Levy; Marco Metra; Bertram Pitt; Piotr Ponikowski; Naoki Sato; Adriaan A Voors; Johannes-Peter Stasch; Javed Butler
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

4.  Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.

Authors:  Jin Yang; Xuhui Feng; Qiong Zhou; Wei Cheng; Ching Shang; Pei Han; Chiou-Hong Lin; Huei-Sheng Vincent Chen; Thomas Quertermous; Ching-Pin Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

5.  Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy.

Authors:  R A Tio; R H J A Slart; R A de Boer; P A van der Vleuten; R M de Jong; L M van Wijk; T Willems; D D Lubbers; A A Voors; D J van Veldhuisen
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

6.  Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community.

Authors:  Yariv Gerber; Shannon M Dunlay; Allan S Jaffe; Joseph P McConnell; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Atherosclerosis       Date:  2008-08-07       Impact factor: 5.162

7.  Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.

Authors:  Michael Bietenbeck; Anca Florian; Zornitsa Shomanova; Claudia Meier; Ali Yilmaz
Journal:  Clin Res Cardiol       Date:  2018-05-17       Impact factor: 5.460

8.  Preservation of NO production by statins in the treatment of heart failure.

Authors:  Jean-Noel Trochu; Seema Mital; Xiao ping Zhang; Xiaobin Xu; Manuel Ochoa; James K Liao; Fabio A Recchia; Thomas H Hintze
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

Review 9.  Multiple Avenues of Modulating the Nitric Oxide Pathway in Heart Failure Clinical Trials.

Authors:  Prabhjot Singh; Shilpa Vijayakumar; Andreas Kalogeroupoulos; Javed Butler
Journal:  Curr Heart Fail Rep       Date:  2018-04

10.  Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.

Authors:  Nazish Sayed; Chun Liu; Mohamed Ameen; Farhan Himmati; Joe Z Zhang; Saereh Khanamiri; Jan-Renier Moonen; Alexa Wnorowski; Linling Cheng; June-Wha Rhee; Sadhana Gaddam; Kevin C Wang; Karim Sallam; Jack H Boyd; Y Joseph Woo; Marlene Rabinovitch; Joseph C Wu
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.